CinnaTropin® is the brand name of recombinant growth hormone (somatropin). Each CinnaTropin® pre-filled pen contains 5 or 10 mg of somatropin as ready-to-use solution. CinnaTropin® is available in a pack containing 1 sterile pre-filled pen and patient information leaflet.CinnaTropin® is indicated for the treatment of pediatric patients with growth failure due to inadequate secretion of endogenous growth hormone (GH).
CinnaTropin® is indicated for the treatment of pediatric patients with short stature associated with Turner syndrome.
CinnaTropin® is indicated for the treatment of pediatric patients with short stature associated with Noonan syndrome.
CinnaTropin® is indicated for the treatment of pediatric patients with short stature associated with Parder-Willi syndrome.
CinnaTropin® is indicated for the treatment of pediatric patients with short stature associated with chronic renal insufficiency.
CinnaTropin® is indicated for the treatment of pediatric patients who have Idiopathic Short Stature (ISS).
CinnaTropin® is indicated for children born small for gestational age (SGA) who failed to show catch-up growth by 4 years of age or later.
CinnaTropin® is indicated for the treatment of adults with childhood-onset or adult-onset growth hormone deficiency.
